Arterial Remodeling Technologies reported today that the Company has achieved a medical milestone with its “ARTDIVA” clinical trial: the successful First-in-Human implantation of its novel biodegradable stent into an 61-year-old male who was suffering from a blocked coronary artery and needed a percutaneous coronary intervention .
More...
More...